PetVivo Holdings

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

PetVivo Holdings reports strong Q1 earnings, eyes market expansion

PetVivo Holdings demonstrated robust financial and operational progress in Q1 2025, driven by strong revenue growth and efficient cost management.
The company's focus on expanding market reach, accelerating Spryng adoption, and enhancing sales and marketing teams positions it for future growth.
While challenges like narrowing net loss persist, PetVivo's strategic initiatives and favorable financial position offer opportunities for sustained success.

PetVivo reports strong Q2 growth, eyes expansion in animal health

PetVivo Holdings delivered impressive financial and operational results in Q2 2025, marked by substantial revenue growth and improved net loss.
With a focus on expanding its distribution network, strategic partnerships, and clinical trials, PetVivo is poised for continued growth and market expansion.
While challenges in scaling operations and maintaining quality exist, the company's commitment to growth and innovation presents significant opportunities for success in the animal health market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company, which engages in the business of licensing and commercializing medical devices and biomaterials for the treatment and management of afflictions and diseases in animals, initially for dogs and horses. The firm's lead product includes Spryng with OsteoCushion Technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Edina, MN.

Conference call begins at 4:00 p.m. Central time today

PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update

MINNEAPOLIS, June 29, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine athletes and companion animals, announced today it has entered into a definitive exclusive distribution services agreement with MWI Animal Health, a leading distributor of animal health products and services and a subsidiary of AmerisourceBergen.

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH

MINNEAPOLIS, MN, US, June 28, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, will provide an update regarding the MWI Distribution Services Agreement and discuss financial results for the year ended March 31, 2022, on Wednesday, June 29, 2022 at 4:00 p.m. CT (5:00 p.m. ET).

PETVIVO HOLDINGS, INC. TO PROVIDE COMPANY UPDATE RELATED TO THE MWI DISTRIBUTION AGREEMENT AND DISCUSS RESULTS FOR THE FISCAL YEAR ENDED MARCH 31, 2022

MINNEAPOLIS, June 01, 2022 (GLOBE NEWSWIRE) -- PetVivo, the company who makes SpryngTM with OsteoCushionTM Technology, is proud to work in collaboration with Dr. Tracy Turner, a recognized expert in equine lameness diagnosis, on new video Q&A sessions on joint health. Dr. Tuner, with more than four decades of experience, has seen the full spectrum of lameness and joint issue management products and when he encountered SpryngTM with OsteoCushionTM Technology, an intra-articular injectable veterinary device, he knew he had come across a potential game-changer.

PetVivo, makers of Spryng™ with OsteoCushion™ Technology, introduces new Q&A sessions with equine expert Dr. Tracy Turner

MINNEAPOLIS, MN / ACCESSWIRE / April 19, 2022 / PetVivo Holdings, Inc. (NASDAQ:PETV)(NASDAQ:PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be presenting at the Planet MicroCap Showcase 2022 at the Bally's Hotel & Casino in Las Vegas, Nevada on Wednesday, May 4, 2022 at 1:00 PM PDT. John Lai, Chief Executive Officer, of PetVivo, will provide an overview of the Company's business during the presentation and will be answering questions from investors.

Petvivo Holdings, Inc. To Present at the Planet Microcap Showcase 2022 in Las Vegas

MINNEAPOLIS, MN, US, April 04, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that Rachael Schumaker has accepted a position with the Company as its new Business Development Manager for the Midwest Region of the United States.

Rachael Schumaker Joins PetVivo Holdings, Inc. as the Midwest Business Development Manager

MINNEAPOLIS, MN, US, March 16, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that David J. Gregory has accepted a position with the Company as its new Regional Sales Manager for the Midwest Region of the United States.

David J. Gregory Joins PetVivo Holdings, Inc. as the Regional Sales Manager

PetVivo Holdings, Inc. (PETV) CEO John Lai on Q3 2022 Results - Earnings Call Transcript

PetVivo Reports Third Quarter 2022 Financial Results

MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, February 10, 2022 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021 [UPDATED]

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021

PetVivo Holdings, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.

PetVivo Holdings to Present at Emerging Growth Conference on January 19, 2022

MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ﻿﻿PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that VetCove, Inc. has agreed to distribute PetVivo's therapeutic product, SPRYNG™ with OsteoCushion™ Technology. VetCove owns and operates a licensed veterinarian ordering/purchasing platform used by over 13,000 veterinary hospitals to compare prices and purchase medications, food and veterinary supplies from multiple vendors at once.

PETVIVO HOLDINGS, INC. ANNOUNCES DISTRIBUTION OF ITS VETERINARY MEDICAL DEVICE, SPRYNG™, BY VETCOVE, INC.

Genius Brands

Petros Pharmaceuticals

These penny stocks are trending right now, are they worth buying? The post Trending Penny Stocks to Buy For Under $4?

Trending Penny Stocks to Buy For Under $4? Check These 3 Out

Bluejay Diagnostics

Bit Brother Ltd

BeyondSpring

Invacare

NuZee, Inc.

OPKO Health

Ring Energy

Spectrum Pharma

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch

Short squeeze penny stocks to watch right now. The post Penny Stocks To Buy For A Short Squeeze?

Penny Stocks To Buy For A Short Squeeze? 5 To Watch Now

MINNEAPOLIS, MN, US, Nov. 30, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the American Association Equine Practitioners (“AAEP”) conference to be held December 4th to December 8th, 2021 at the Music City Center in Nashville, Tennessee.

PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in Nashville, Tennessee

Compass Therapeutics

Liquidia Technologies Inc

 Orbital Energy Group, Inc.

OpGen

Hot penny stocks insiders are buying in November The post 5 Penny Stocks To Buy Now According To Insiders In November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Penny Stocks To Buy Now According To Insiders In November 2021

PetVivo Holdings, Inc. (PETV) CEO John Lai on Q2 2022 Results - Earnings Call Transcript

Raised approximately 11.25 million in connection with Initial Public Offer ing

PetVivo Reports Second Quarter 2022 Financial Results - Updated

PetVivo Reports Second Quarter 2022 Financial Results

MINNEAPOLIS, MN, US, Nov. 11, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will release financial results for the second fiscal year quarter 2022 on Monday, November 15, 2021 after market close. The company will host a Q&A conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.

PETVIVO HOLDINGS, INC. TO ANNOUNCE SECOND QUARTER 2022 RESULTS

Advaxis

Powerbridge Technologies Co Ltd

Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks That Retail Traders Are Watching Right Now

Ambev

Check these penny stocks out for your November watchlist The post Hot Penny Stocks You Need to Know About in November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks You Need to Know About in November

MINNEAPOLIS, MN, US, Oct. 27, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, today announced that it has named Kick (“Ideas that Kick”) as its advertising agency across multiple marketing services disciplines. Kick will lead brand strategy, advertising, digital and social media, experiential marketing and design strategies for PetVivo.

News for PetVivo Holdings Stock (PETV)